pre-IPO PHARMA

COMPANY OVERVIEW

Tango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.tangotx.com


    CAREER WEBSITE

    https://www.tangotx.com/join-us/


    SOCIAL MEDIA


    INVESTORS

    third-rock-ventures


    PRESS RELEASES


    Aug 3, 2021

    Tango Therapeutics to Participate in the 12th Annual Wedbush PacGrow Healthcare Conference


    Apr 14, 2021

    Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies


    Mar 24, 2021

    Tango Therapeutics Appoints Mace Rothenberg, MD, and Lesley Ann Calhoun, CPA, to Board of Directors


    Aug 17, 2020

    Tango Therapeutics Announces $50 Million Equity Financing


    Aug 17, 2020

    Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration


    For More Press Releases


    Google Analytics Alternative